Align Technology | ALGN - Eigenkapital Und Reserven





Eigenkapital Und Reserven Veränderung Datum
3M USD 3.26B 1.48B 2026-03
Align Technology USD 4.15B 100.27M 2026-03
Becton, Dickinson and Co. USD 24.13B 1.15B 2026-03
Bruker USD 2.46B 35.9M 2025-12
Cardinal Health USD -2.83B 52M 2026-03
Charles River Laboratories USD 2.9B 265.94M 2026-03
Cooper Companies USD 8.36B 124.7M 2025-12
CVS Health USD 77.46B 2.24B 2026-03
Danaher USD 52.95B 415M 2026-03
Dentsply International USD 1.32B 21M 2026-03
Dexcom USD 2.96B 210.9M 2026-03
Henry Schein USD 3.27B 21M 2026-03
Idexx Laboratories USD 1.56B 49.28M 2026-03
Insulet USD 1.3B 212.6M 2026-03
Integra LifeSciences USD 1.04B 1.06M 2026-03
IQVIA Holdings USD 6.22B 282M 2026-03
Masimo USD 788.9M 67.7M 2026-03
McKesson USD -2.17B 874M 2026-03
Mettler Toledo International USD -41.88M 18.25M 2026-03
Revvity USD 7.25B 125.54M 2025-12
Solventum Corp USD 4.97B 80M 2026-03
Stryker USD 22.42B 635M 2025-12
Teleflex USD 3.08B 40.33M 2026-03
Thermo Fisher Scientific USD 51.93B 1.6B 2026-03
Veeva Systems USD 7.3B 89.6M 2026-03
Waters USD 2.56B 230.55M 2025-12
Zimmer Biomet Holdings USD 12.68B 16.1M 2026-03
Zoetis USD 3.23B 98M 2026-03